The Clinical Study Of The Therapy Of Medieated Plaster Applied To A Accuaccupoint In Preventing Postoperative Nausea And Vomiting After A Gynecological Laparoscopic Surgery

ObjectivesPostoperative nausea and vomiting (PONV) is a common complication after a surgery.This study researchs the curative effect and safety of medieated plaster applied to an accuaccupoint in preventing postoperative nausea and vomiting after a gynecological laparoscopic surgery, and explore its feasibility and clinical significance,hence sheding light on clinical treatment.MethosdsThis research design was Clinical stochastic control experiment.123patients who were suitable to receive a gynecological laparoscopic surgery were divided into3groups. The patients from the treatment group (receiving the medieated plaster of evodia rutaecarpa plus cinnamomum cassia) received the therapy of medieated plaster applied to the acupoints (zu sanli S36;ST36and nei guan P6;PC6on both sides) by the same doctor within30minutes after the surgery, and took off the plaster24hours later. The patients from the placebo group were applied placebo to the acupoints in the same way as the treatment group. The patients from the blank controller received no treatment. The doctor recorded and observed if the patients expirenced nausea and vomiting in24hours, as well as the time they first experienced nausea and vomiting. They analysed the degree of nausea by nausea visual analog Scale(NVAS), observed the overall degree of satisfaction to the prevention of nausea and vomiting after a surgery by the Likert scale method,and observed if there was any untoward reaction. Resul ts of all the data used SPSS17.0statistical software for analysis, P<0.05for a significant difference.Result The ratio of nausea and vomiting by the treatment group in24hours is17.5%, while the control group40%. The difference of PONVof the two groups is significant (P<0.05).The average NVAS scale of the treatment group is3.22+1.08, whearas the control group4.17+-6.09. The difference of degree of nausea of both groups in24hours is significant (P<0.05).The average time when the patients of both groups first expirenceed nausea and vomiting was5.45+0.68hours and4.93+0.52hours respectively, with no significant difference (P>0.05).85%of the patients from the treatment group were satisfiecd with the PONV theorapy, while the control group,75%. The difference of the total degree of satisfaction from both groups is not significant (P>0.05).Conclusionl.The ratio of nausea and vomiting by the treatment group in24hours is15.0%, while the placebo group,36.6%, the blank controller,52.5%. The difference of PONV of the treatment group is significant (P<0.05) compared with the placebo group and the blank controller respectively, whereas the difference between the placebo group and the blank controller was not significant(P>0.05).2. The average NVAS scale of the treatment group is3.45+1.08, whearas the placebo group,4.66+0.93, the blank controller,5.15+1.20. The average time when the patients of the treatment group first expirenceed nausea and vomiting was5.25+0.68hours, the placebo group,4.63+0.52hours, and the blank controller,4.42+0.48hours. The difference of PONV and the average time when the patients of the treatment group first expirenceed nausea and vomiting is significant (P<0.05) compared with the placebo group and the blank controller respectively, but the difference between the placebo group and the blank controller was not signi ficant (P>0.05).3.92.5%of the patients from the treatment group were satisfied with the PONV theorapy, while the placebo group,65.9%, and the blank control ler,50.0%. The difference of the total degree of satisfaction to the prevention of PONV of the treatment group is significant (P<0.05) compared with the placebo group and the blank controller respectively, whereas the difference between the placebo group and the blank controller was not signi ficant (P>0.05).